Sponsor Pipeline

Clinton Bahler Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-14 NCT06849544
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78…		 Trial completed
2026-08-14 NCT06849544
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78…		 date change Completion pushed: 2026-07 -> 2026-08-06
2026-07-29 NCT06849544
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78…		 Enrollment closed, study ongoing
2026-07-29 NCT06849544
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78…		 date change Completion moved earlier: 2026-08 -> 2026-07
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-24 NCT07725523 Safety and Efficacy of OTL78 (Zopocianine) Phase 2/3 Not Yet Recruiting
Active Trials by Phase
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07725523 Safety and Efficacy of OTL78 (Zopocianine) Prostate Cancer Surgery Not Yet Recruiting
Disease Areas
Prostate Cancer (1)
Get alerts when Clinton Bahler's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free